Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
DomainIPT

EBF1 NFAT5

1.03e-0327332SM00429
DomainTIG

EBF1 NFAT5

1.36e-0331332PF01833
DomainIPT

EBF1 NFAT5

1.45e-0332332IPR002909
DomainMAGE

MAGEB4 TRO

1.64e-0334332SM01373
DomainMAGE

MAGEB4 TRO

1.84e-0336332PS50838
DomainMHD_dom

MAGEB4 TRO

1.84e-0336332IPR002190
DomainMAGE

MAGEB4 TRO

1.84e-0336332PF01454
Domainp53-like_TF_DNA-bd

RUNX3 NFAT5

3.94e-0353332IPR008967
DomainZINC_FINGER_C2H2_2

ZFHX3 ZNF469 ZNF592 TSHZ2 ZNF503

1.10e-02775335PS50157
DomainZINC_FINGER_C2H2_1

ZFHX3 ZNF469 ZNF592 TSHZ2 ZNF503

1.11e-02777335PS00028
DomainZnf_C2H2-like

ZFHX3 ZNF469 ZNF592 TSHZ2 ZNF503

1.22e-02796335IPR015880
PathwayREACTOME_RUNX3_REGULATES_CDKN1A_TRANSCRIPTION

ZFHX3 RUNX3

3.47e-056222MM15534
PathwayREACTOME_RUNX3_REGULATES_CDKN1A_TRANSCRIPTION

ZFHX3 RUNX3

4.86e-057222M27807
Pubmed

Lineage-specific RUNX3 hypomethylation marks the preneoplastic immune component of gastric cancer.

RUNX3 IL6ST

9.28e-07234225088199
Pubmed

Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response to TGF-beta signal transduction.

ZFHX3 RUNX3

9.28e-07234220599712
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

NAV3 CHD6 NFAT5 UBR5 TRO KIF1B

2.52e-0640734612693553
Pubmed

Zfhx3 is required for the differentiation of late born D1-type medium spiny neurons.

ZFHX3 EBF1 ZNF503

3.07e-062934331491374
Pubmed

Dlx1&2 and Mash1 transcription factors control MGE and CGE patterning and differentiation through parallel and overlapping pathways.

ZFHX3 EBF1 TSHZ2 ZNF503

7.92e-0613034419386638
Pubmed

Dlx1&2 and Mash1 transcription factors control striatal patterning and differentiation through parallel and overlapping pathways.

ZFHX3 EBF1 TSHZ2 ZNF503

8.93e-0613434419030180
Pubmed

Runx1-Cbfβ facilitates early B lymphocyte development by regulating expression of Ebf1.

EBF1 RUNX3

9.26e-06534222665574
Pubmed

Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.

SERTAD2 ZFHX3 EBF1 PER3 RUNX3 NFAT5 ZNF592

1.11e-0580834720412781
Pubmed

The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.

ZFHX3 RUNX3 NFAT5 ATXN1L ZNF592 DCLK1

1.95e-0558334629844126
Pubmed

Transcriptional heterogeneity of ventricular zone cells in the ganglionic eminences of the mouse forebrain.

ZFHX3 EBF1 ZNF503

2.81e-056034335175194
Pubmed

A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart.

NFAT5 CLIP1 KIF1B

2.81e-056034319075228
Pubmed

Formation of the Mouse Internal Capsule and Cerebral Peduncle: A Pioneering Role for Striatonigral Axons as Revealed in Isl1 Conditional Mutants.

ZFHX3 EBF1

7.19e-051334235273083
Pubmed

Molecular heterogeneity of developing retinal ganglion and amacrine cells revealed through single cell gene expression profiling.

ZFHX3 EBF1

1.10e-041634217444492
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

MAST2 ZNF592 CLIP1 IL6ST KIF1B

1.15e-0449734523414517
Pubmed

The transcription factor Zfp503 promotes the D1 MSN identity and represses the D2 MSN identity.

EBF1 ZNF503

1.25e-041734236081908
Pubmed

An overview of the MAGE gene family with the identification of all human members of the family.

MAGEB4 TRO

1.41e-041834211454705
Pubmed

Promyelocytic leukemia protein interacts with the apoptosis-associated speck-like protein to limit inflammasome activation.

TSHZ2 IL6ST

1.93e-042134224407287
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

NAV3 CHD6 ZNF592 WDR59 DCLK1 KIF1B ITGB3BP

2.07e-04128534735914814
Pubmed

Axonal projections of mechanoreceptive dorsal root ganglion neurons depend on Ret.

EBF1 RUNX3

2.32e-042334220534675
Pubmed

Genome-wide association analyses identify variants in developmental genes associated with hypospadias.

ZFHX3 EBF1

2.74e-042534225108383
Pubmed

Rhombomere-specific analysis reveals the repertoire of genetic cues expressed across the developing hindbrain.

EBF1 ZNF503

3.21e-042734219208226
Pubmed

Identification of Arx transcriptional targets in the developing basal forebrain.

EBF1 ZNF503

3.45e-042834218799476
Pubmed

Multimodal Hox5 activity generates motor neuron diversity.

EBF1 TSHZ2

3.70e-042934239289460
Pubmed

Transcriptome analysis of mouse stem cells and early embryos.

MAGEB4 CHD6 MAST2 TSHZ2

4.23e-0436334414691545
Pubmed

The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.

LRIG2 ATXN1L ZNF503

4.43e-0415234338360978
Pubmed

Dlx1/2-dependent expression of Meis2 promotes neuronal fate determination in the mammalian striatum.

EBF1 ZNF503

4.52e-043234235156680
Pubmed

Ctip2 controls the differentiation of medium spiny neurons and the establishment of the cellular architecture of the striatum.

EBF1 ZNF503

4.81e-043334218199763
Pubmed

The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis.

EBF1 RUNX3 UBR5 CLIP1

5.86e-0439634426687479
Pubmed

A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.

SERTAD2 ZFHX3 EBF1 NFAT5 KIF1B

5.92e-0470934522988430
Pubmed

Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex.

MAST2 CLIP1

6.05e-043734227565344
Pubmed

E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.

MAGEB4 CHD6 ATXN1L ZNF592 TOPAZ1

7.01e-0473634529676528
Pubmed

Transcriptional Networks Controlled by NKX2-1 in the Development of Forebrain GABAergic Neurons.

EBF1 ZNF503

7.07e-044034227657450
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

ZFHX3 CHD6 UBR5 ZNF592

7.17e-0441834434709266
Pubmed

Parcellation of the striatal complex into dorsal and ventral districts.

EBF1 ZNF503

7.79e-044234232170006
Pubmed

A GO catalogue of human DNA-binding transcription factors.

ZNF469 ZNF592

7.79e-044234234673265
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

MAST2 UBR5 CLIP1 KIF1B

9.12e-0444634424255178
CytobandEnsembl 112 genes in cytogenetic band chr16q22

ZFHX3 NFAT5 ATXN1L MTSS2

1.03e-05183344chr16q22
CytobandEnsembl 112 genes in cytogenetic band chr1p36

PER3 RUNX3 PLCH2 KIF1B

1.56e-03681344chr1p36
Cytoband16q22.1

NFAT5 MTSS2

3.04e-0311034216q22.1
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZFHX3 TSHZ2

1.34e-0415212529
GeneFamilyMAGE family

MAGEB4 TRO

9.76e-04402121136
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZFHX3 ZNF469 ZNF592 TSHZ2 ZNF503

1.17e-0371821528
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HDA

NAV3 ZFHX3 EBF1 MAST2 TMEM121B DCLK1

3.57e-05506336M39067
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HDA1

NAV3 ZFHX3 MAST2 TSHZ2 TMEM121B DCLK1

7.91e-05584336M39068
CoexpressionGSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN

SERTAD2 NFAT5 TSHZ2 IL6ST

9.10e-05189334M3112
CoexpressionGSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP

LINS1 ATXN1L ZNF592 TNFRSF21

9.86e-05193334M4177
CoexpressionHE_LIM_SUN_FETAL_LUNG_C0_PERICYTE

EBF1 CLIP1 TNFRSF21 MTSS2

1.03e-04195334M45684
CoexpressionGSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_UP

MAGEB4 EBF1 TSHZ2 TRO

1.11e-04199334M8105
CoexpressionGSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN

PER3 IL6ST KIF1B ITGB3BP

1.13e-04200334M8480
CoexpressionGSE14350_IL2RB_KO_VS_WT_TEFF_UP

LRIG2 MAST2 NFAT5 DCLK1

1.13e-04200334M3423
CoexpressionGSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP

NAV3 RUNX3 MAST2 PYHIN1

1.13e-04200334M6514
CoexpressionLAKE_ADULT_KIDNEY_C28_INTERSTITIUM

EBF1 TSHZ2 IL6ST

1.73e-0486333M39247
ToppCelldroplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TSHZ2 TRO IL6ST MTSS2 ZNF503

3.47e-07193345826b8dd801298b3e0cd76232feae5a14026b8806
ToppCelldroplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TSHZ2 TRO IL6ST MTSS2 ZNF503

3.47e-0719334587d3a577d37fb0cb4b6313c596310de452bc3872
ToppCelldroplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TSHZ2 TRO IL6ST MTSS2 ZNF503

3.47e-07193345d485634c564b268e344b6a2863c26f6adaec9e38
ToppCellRV-14._Fibroblast_III|RV / Chamber and Cluster_Paper

ZFHX3 EBF1 TSHZ2 DCLK1

3.87e-06140344b4fee8eb6bf855b364b00bda3f78e49d851bbca0
ToppCellAdult-Mesenchymal-chondrocyte-D175|Adult / Lineage, Cell type, age group and donor

NAV3 EBF1 TSHZ2 DCLK1

7.97e-0616834414071b961c9bdb54a8259b12a88237b802cbde36
ToppCellRA-01._Fibroblast_I|RA / Chamber and Cluster_Paper

ZFHX3 EBF1 TSHZ2 DCLK1

8.16e-061693446373562ab3b1765060212a6a53d6543e7e942e80
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NAV3 EBF1 TSHZ2 DCLK1

9.36e-06175344795a6564d5a75ffd35d39f5274b9e8d28708bbc8
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

RUNX3 TSHZ2 PLCH2 PYHIN1

9.36e-0617534416c835e62a3321f6cf6163954889946bbb869498
ToppCellLA-01._Fibroblast_I|LA / Chamber and Cluster_Paper

ZFHX3 EBF1 TSHZ2 DCLK1

1.02e-05179344dcb6ec9ae72b13fe388b72dace2815293fafe8ee
ToppCellRA-01._Fibroblast_I|World / Chamber and Cluster_Paper

ZFHX3 EBF1 TSHZ2 DCLK1

1.07e-051813442b6ddeb53a79a658e2ba78527ff48c155b20daa6
ToppCelldroplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

WDR59 IL6ST MTSS2 ZNF503

1.09e-05182344b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01
ToppCell5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NAV3 EBF1 TSHZ2 DCLK1

1.14e-051843444d4d8f3f44c67d74c57e7af7b7c158f0157b2f49
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NAV3 EBF1 TSHZ2 DCLK1

1.14e-05184344e061e85c4bb19f49f6451ddd7a9077d7378ee365
ToppCellAdult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor

NAV3 EBF1 TSHZ2 DCLK1

1.14e-051843442b7e6f91e11c228f0521e099886867d9e998e78d
ToppCellAdult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor

NAV3 EBF1 TSHZ2 DCLK1

1.17e-05185344fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804
ToppCellCOVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations)

NAV3 EBF1 TSHZ2 DCLK1

1.17e-05185344a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCellLA-01._Fibroblast_I|World / Chamber and Cluster_Paper

ZFHX3 EBF1 TSHZ2 DCLK1

1.22e-051873444ea486991f66c29728d127171a07b81404ec0b78
ToppCellControl-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations)

NAV3 EBF1 TSHZ2 DCLK1

1.24e-05188344706a26c372add839d947749f0521a0e1f5c9b0ec
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

EBF1 TSHZ2 DCLK1 IL6ST

1.29e-051903441121eb607a984c59fbffe7220837fc178745aa55
ToppCellLV-01._Fibroblast_I|World / Chamber and Cluster_Paper

ZFHX3 EBF1 TSHZ2 DCLK1

1.29e-0519034412992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCellAdult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor

NAV3 EBF1 TSHZ2 DCLK1

1.29e-051903447dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

EBF1 TSHZ2 CLIP1 DCLK1

1.29e-051903440fea33f2dc1efa23aaa2da1c318482a52a313ff1
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

EBF1 TSHZ2 DCLK1 IL6ST

1.29e-05190344048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NAV3 EBF1 TSHZ2 DCLK1

1.29e-05190344efb757f11c2809e66ddb48a5c84f5433f111cb7c
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NAV3 EBF1 TSHZ2 DCLK1

1.32e-05191344107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCellLV-02._Fibroblast_II|World / Chamber and Cluster_Paper

ZFHX3 EBF1 TSHZ2 DCLK1

1.32e-05191344d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCellRV-01._Fibroblast_I|World / Chamber and Cluster_Paper

ZFHX3 EBF1 TSHZ2 DCLK1

1.32e-0519134470c067c54084bfb02c29bab085f4defd477194fb
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NAV3 EBF1 TSHZ2 DCLK1

1.32e-05191344bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NAV3 EBF1 TSHZ2 DCLK1

1.32e-051913442c51850f5c559d665b8a27a12b75af9ed58dffe1
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

NAV3 EBF1 TSHZ2 DCLK1

1.35e-051923448d56e360ebc624ca4cd7f0af4f3cc599c244f134
ToppCellhuman_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

CHD6 NFAT5 UBR5 WDR59

1.35e-05192344916fbec1c7ab7969bda711886ac88e877e30c280
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NAV3 EBF1 TSHZ2 DCLK1

1.35e-051923445105e4b577408b4e1a62d0a44c23c2b830ccad88
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NAV3 EBF1 TSHZ2 DCLK1

1.35e-05192344d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

NAV3 EBF1 TSHZ2 DCLK1

1.35e-05192344e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81
ToppCellAdult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor

NAV3 EBF1 TSHZ2 DCLK1

1.35e-05192344d21f0f577156f17c899b08871046a26b88aea011
ToppCellRV-01._Fibroblast_I|RV / Chamber and Cluster_Paper

ZFHX3 EBF1 TSHZ2 DCLK1

1.35e-05192344356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCellMesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor

NAV3 EBF1 TSHZ2 DCLK1

1.35e-05192344a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCellhuman_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)

CHD6 TSHZ2 WDR59 MTSS2

1.38e-05193344503a979328c68b096680b71359a26f02fafdff35
ToppCellLA|World / Chamber and Cluster_Paper

ZFHX3 EBF1 TSHZ2 DCLK1

1.38e-05193344d4bf89437216baf489ea0239136dcedf3b6714af
ToppCellE18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ZFHX3 EBF1 TRO DCLK1

1.38e-05193344469a7f1c2ff7137cc5a064464456911f67f92e70
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

NAV3 EBF1 TSHZ2 DCLK1

1.38e-051933449ab47b360bee1d4f1092c2269e58acebe9584021
ToppCellLV-01._Fibroblast_I|LV / Chamber and Cluster_Paper

ZFHX3 EBF1 TSHZ2 DCLK1

1.38e-05193344dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NAV3 EBF1 TSHZ2 DCLK1

1.38e-0519334409a9ab029f01234459a88e3e994fe90ef4cbb8c6
ToppCellE18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ZFHX3 EBF1 TRO DCLK1

1.38e-05193344323d1f3f4fbeb93ba857fc135d8aa0b897f98ac5
ToppCellhuman_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells)

CHD6 NFAT5 UBR5 WDR59

1.38e-05193344e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

NAV3 EBF1 TSHZ2 DCLK1

1.38e-05193344261cafc167c86ab277be4ea7f08b0173e2dde26e
ToppCellRV-02._Fibroblast_II|RV / Chamber and Cluster_Paper

ZFHX3 EBF1 TSHZ2 DCLK1

1.40e-0519434411c79a8c56ece42713b04b321982e41e239f07a5
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NAV3 EBF1 TSHZ2 DCLK1

1.40e-05194344c49f72441b3557e2c3a9c4239e68c0cf0652814b
ToppCellLV-02._Fibroblast_II|LV / Chamber and Cluster_Paper

ZFHX3 EBF1 TSHZ2 DCLK1

1.40e-05194344014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCellLA-02._Fibroblast_II|LA / Chamber and Cluster_Paper

ZFHX3 EBF1 TSHZ2 DCLK1

1.40e-05194344234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

NAV3 EBF1 TSHZ2 DCLK1

1.40e-05194344439d3f17c1f4736122b330e98add9292c7036a8e
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

NAV3 EBF1 TSHZ2 DCLK1

1.43e-05195344ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NAV3 EBF1 TSHZ2 DCLK1

1.43e-051953443c3703f092b6fc1b7333426fb5e2823bfb74bb57
ToppCellRV-02._Fibroblast_II|World / Chamber and Cluster_Paper

ZFHX3 EBF1 TSHZ2 DCLK1

1.43e-05195344ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCellRA-02._Fibroblast_II|RA / Chamber and Cluster_Paper

ZFHX3 EBF1 TSHZ2 DCLK1

1.43e-051953446a02ebbeb3199447ddce64d92d8809436e040eba
ToppCellIPF-Stromal-Fibroblast|World / Disease state, Lineage and Cell class

NAV3 EBF1 TSHZ2 DCLK1

1.43e-051953449c32756edb54f0c211185d9a98073fe01fd1526a
ToppCellLA-02._Fibroblast_II|World / Chamber and Cluster_Paper

ZFHX3 EBF1 TSHZ2 DCLK1

1.43e-05195344a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCellControl-Stromal-Fibroblast|Control / Disease state, Lineage and Cell class

NAV3 EBF1 TSHZ2 DCLK1

1.46e-051963447ca94477498a84cafcdd9933ee92a6cbde76c70e
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

RUNX3 TSHZ2 IL6ST PYHIN1

1.46e-05196344e4c76e7ad68455e51fe93ce588bcec9383f8654b
ToppCellChildren_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor

NAV3 EBF1 TSHZ2 DCLK1

1.46e-05196344bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ZFHX3 EBF1 TSHZ2 DCLK1

1.46e-05196344b8759e6231e0254797d6c30930407b79440c57bb
ToppCellControl-Stromal-Fibroblast|World / Disease state, Lineage and Cell class

NAV3 EBF1 TSHZ2 DCLK1

1.46e-051963441ec7a4daa51b3156db97e1fd6cb925ad311bb4b5
ToppCellIPF-Stromal-Fibroblast|IPF / Disease state, Lineage and Cell class

NAV3 EBF1 TSHZ2 DCLK1

1.46e-05196344f7ae604ba32b322d86d68b2b54892e7c6ab06c49
ToppCellCOPD-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class

NAV3 EBF1 TSHZ2 DCLK1

1.46e-051963444930eeb303d174c28fd91021723e26fdf1af9170
ToppCellRA-02._Fibroblast_II|World / Chamber and Cluster_Paper

ZFHX3 EBF1 TSHZ2 DCLK1

1.46e-05196344e8cbda03837f1f26470a9d93aa7fdaa04e08e38a
ToppCell5'-GW_trimst-2-LymphNode-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

EBF1 TSHZ2 DCLK1 IL6ST

1.49e-051973445fbbc570a4e77c703f569a4f85ce2d8af67d6297
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.

ZFHX3 EBF1 TSHZ2 ZNF503

1.49e-051973444961f66606f08e399508fd6cabca588e7ab406a8
ToppCell5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NAV3 TSHZ2 DCLK1 ZNF503

1.49e-051973442744cc94883c5d0424677cf5093bbab622933e9b
ToppCellCOVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations)

NAV3 EBF1 TSHZ2 DCLK1

1.49e-05197344fb847f2277609c31fffcdf49517243ce0684facf
ToppCellCOVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type

NAV3 EBF1 TSHZ2 DCLK1

1.52e-05198344ca26ca460856b1faaa3e83766da6abdf63af2b51
ToppCellCOPD-Stromal-Fibroblast|World / Disease state, Lineage and Cell class

NAV3 EBF1 TSHZ2 DCLK1

1.52e-051983442f13c0b3372af53d1bd85f9546f315c878580a71
ToppCellAdult-Mesenchymal|Adult / Lineage, Cell type, age group and donor

NAV3 EBF1 TSHZ2 DCLK1

1.52e-0519834426e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

EBF1 TSHZ2 DCLK1 IL6ST

1.52e-05198344a860246bcea847249a78fd2e86ed8e04371060db
ToppCellCOPD-Stromal-Fibroblast|COPD / Disease state, Lineage and Cell class

NAV3 EBF1 TSHZ2 DCLK1

1.52e-051983447904af61473cb20064f7a3a1e1bfe8d5913cf317
ToppCellControl-Stromal|Control / Disease state, Lineage and Cell class

NAV3 EBF1 TSHZ2 DCLK1

1.52e-05198344ae726b6b7f0a4107899be4d32ac256ffa0bd8d59
ToppCell3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NAV3 EBF1 TSHZ2 DCLK1

1.55e-051993449846d6a31635fde759d55674631c11ab9270a603
ToppCell3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NAV3 EBF1 TSHZ2 DCLK1

1.55e-05199344bfc157be6e9f84739848eb19b718de5b17f3fa88
ToppCellMesenchymal|World / Lineage, Cell type, age group and donor

NAV3 EBF1 TSHZ2 DCLK1

1.55e-051993444bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

NAV3 EBF1 TSHZ2 DCLK1

1.55e-05199344993fa050a095017135a6e723c77cd38b9d782e58
ToppCelldistal-1-mesenchymal-Lipofibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

ZNF469 EBF1 TSHZ2 DCLK1

1.55e-05199344a8293db3c42a8d30897858b49aae7acfc18663ba
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

NAV3 EBF1 TSHZ2 DCLK1

1.55e-05199344f835e7ffe976843b0edbf695762d463da85793f3
ToppCellBronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

NAV3 EBF1 TSHZ2 DCLK1

1.58e-05200344ad3fdcef895400f929f2ae12ff9bd85fd46adb3a
ToppCellBronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

NAV3 EBF1 TSHZ2 DCLK1

1.58e-05200344cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCellBronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

NAV3 EBF1 TSHZ2 DCLK1

1.58e-05200344389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell(5)_Fibroblast-E|World / Lung cell shreds - cell class (v4) and cell subclass (v4)

NAV3 EBF1 TSHZ2 DCLK1

1.58e-0520034475e5ecb05e965e24d569aa2ef5cdf740b1528c06
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

NAV3 EBF1 TSHZ2 DCLK1

1.58e-0520034474e74123ea7bf38d337a3a0248a6a51437c6ab42
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

LINS1 TSHZ2 IL6ST

3.87e-058634379c4326df78f0a5b3ef13b2fb4e5074934536e35
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9

LRIG2 UBR5 KIF1B

1.48e-041353433351e8b9e417397c5fa9f856184ff24ce1a27242
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

NAV3 ZFHX3 IL6ST

1.48e-041353439f9d0787a2e99207a9caa88a85565189ab8b940a
ToppCellPND07-28-samps-Lymphocyte-B_cell-B_cell_2|PND07-28-samps / Age Group, Lineage, Cell class and subclass

EBF1 RUNX3 PYHIN1

1.54e-041373432544d1256f11da6e3bad24a871b2253e0ab20d01
ToppCellPND07-28-samps-Lymphocyte-B_cell|PND07-28-samps / Age Group, Lineage, Cell class and subclass

EBF1 RUNX3 PYHIN1

1.54e-04137343874e2eaa7846a2832f46b77c726d79f220a4a1cd
ToppCellLymphoid-Lymphoid-B_cells|Lymphoid / shred on cell class and cell subclass (v4)

CHD6 EBF1 PYHIN1

2.01e-041503435ebf6b4b9b029422a4676ba09a6a9225bd25db47
ToppCell3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NAV3 TSHZ2 TNFRSF21

2.01e-04150343909ccab92855f5f049dc29593aadab1ea973297b
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

NAV3 ZFHX3 IL6ST

2.05e-041513432f9b3e14c2fa6e2b1976ca6ab2031b63bf5e3e64
ToppCellLPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ZFHX3 EBF1 TNFRSF21

2.26e-041563436365b69ede98bc866e996bc52736b00401aacf6f
ToppCell367C-Lymphocytic-NK_cells-NK_cell_C|367C / Donor, Lineage, Cell class and subclass (all cells)

RUNX3 TOPAZ1 PYHIN1

2.26e-04156343a1b9e7621b646d354c2ccd850ce6a4fa9ff8a026
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TSHZ2 DCLK1 PYHIN1

2.39e-04159343cbb331eb689d8cea9e1146ba85e0a05d23301c47
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TSHZ2 DCLK1 PYHIN1

2.39e-04159343330ecbba97d47bc818a5e8d1d84b05d056bd831e
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NAV3 EBF1 DCLK1

2.48e-04161343a006491c991e6a134be20ad75092a91f3b7c3c91
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

NAV3 EBF1 DCLK1

2.48e-041613434f25eeabb841b0b9204cdd4e71d5e131e7868184
DrugAnisomycin [22862-76-6]; Up 200; 15uM; MCF7; HT_HG-U133A

SERTAD2 LINS1 NFAT5 IL6ST

8.60e-051623342658_UP
DrugDigitoxigenin [143-62-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A

LINS1 NFAT5 WDR59 IL6ST

9.24e-051653343275_UP
Drugretinoic acid; Down 200; 1uM; HL60; HT_HG-U133A

NAV3 TNFRSF21 WDR59 MTSS2

1.50e-041873342671_DN
DrugResveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A

NFAT5 CLIP1 WDR59 IL6ST

1.66e-041923342865_DN
DrugVincamine [1617-90-9]; Up 200; 11.2uM; PC3; HT_HG-U133A

NAV3 NFAT5 IL6ST PYHIN1

1.69e-041933344341_UP
Drug5279552; Down 200; 22uM; MCF7; HT_HG-U133A_EA

LRIG2 ZFHX3 NFAT5 MTSS2

1.76e-04195334843_DN
DrugTrichlormethiazide [133-67-5]; Down 200; 10.6uM; PC3; HT_HG-U133A

ZFHX3 RUNX3 WDR59 MTSS2

1.76e-041953344198_DN
DrugRacecadotril [81110-73-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A

PER3 MAST2 TRO IL6ST

1.79e-041963342774_UP
DrugCorynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; PC3; HT_HG-U133A

ZFHX3 PER3 WDR59 MTSS2

1.79e-041963344227_DN
DrugLevodopa [59-92-7]; Up 200; 20.2uM; HL60; HG-U133A

LRIG2 MAST2 NFAT5 IL6ST

1.83e-041973341972_UP
DrugParoxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A

NAV3 RUNX3 NFAT5 IL6ST

1.83e-041973344556_DN
DrugHydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; PC3; HT_HG-U133A

ZFHX3 RUNX3 MAST2 MTSS2

1.83e-041973342119_UP
DrugBenzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; PC3; HT_HG-U133A

ZFHX3 RUNX3 NFAT5 IL6ST

1.83e-041973344501_DN
DrugClenbuterol hydrochloride [21898-19-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A

ZFHX3 TNFRSF21 WDR59 MTSS2

1.83e-041973343228_DN
DrugGliclazide [21187-98-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A

NFAT5 UBR5 CLIP1 WDR59

1.83e-041973342870_DN
DrugParbendazole [14255-87-9]; Up 200; 16.2uM; MCF7; HT_HG-U133A

RUNX3 CLIP1 TRO DCLK1

1.83e-041973343881_UP
Drugdexamethasone; Up 200; 1uM; MCF7; HG-U133A

MAST2 TSHZ2 TNFRSF21 PYHIN1

1.83e-04197334255_UP
DrugGuanadrel sulfate [22195-34-2]; Up 200; 7.6uM; PC3; HT_HG-U133A

TRO DCLK1 PLCH2 MTSS2

1.83e-041973343698_UP
DrugSulindac [38194-50-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A

LRIG2 LINS1 TNFRSF21 IL6ST

1.83e-041973341693_DN
DrugDiphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; PC3; HT_HG-U133A

NFAT5 IL6ST MTSS2 PYHIN1

1.83e-041973344299_UP
DrugGastrografin

CLIP1 TRO

1.83e-0414332CID000008566
DrugAltretamine [654-05-6]; Down 200; 19uM; PC3; HT_HG-U133A

LINS1 RUNX3 WDR59 MTSS2

1.86e-041983344627_DN
DrugPhenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; MCF7; HT_HG-U133A

LINS1 ZFHX3 TNFRSF21 WDR59

1.86e-041983345298_DN
DrugMuramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; HL60; HT_HG-U133A

NFAT5 ZNF592 TNFRSF21 WDR59

1.86e-041983341326_DN
DrugAmiprilose hydrochloride [60414-06-4]; Down 200; 11.8uM; HL60; HT_HG-U133A

ZFHX3 CLIP1 TRO MTSS2

1.86e-041983343000_DN
DrugMeglumine [6284-40-8]; Down 200; 20.4uM; PC3; HT_HG-U133A

NAV3 PER3 NFAT5 IL6ST

1.86e-041983346685_DN
DrugSolanine alpha [20562-02-1]; Down 200; 4.6uM; PC3; HT_HG-U133A

RUNX3 WDR59 IL6ST MTSS2

1.90e-041993344087_DN
DrugSulfadimethoxine [122-11-2]; Up 200; 12.8uM; PC3; HT_HG-U133A

MAST2 WDR59 DCLK1 MTSS2

1.90e-041993343702_UP
DrugChrysin [480-40-0]; Up 200; 15.8uM; MCF7; HT_HG-U133A

TSHZ2 WDR59 MTSS2 PYHIN1

1.90e-041993345505_UP
DrugNitrofurantoin [67-20-9]; Up 200; 16.8uM; HL60; HT_HG-U133A

MAST2 TNFRSF21 TRO MTSS2

1.90e-041993342341_UP
Drug1,1-dimethylbiguanide hydrochloride; Down 200; 1000uM; MCF7; HG-U133A

ZFHX3 RUNX3 TSHZ2 TNFRSF21

1.90e-041993344_DN
DrugDiazoxide [364-98-7]; Up 200; 17.4uM; HL60; HG-U133A

MAST2 NFAT5 CLIP1 KIF1B

1.94e-042003341368_UP
Diseaseglucose metabolism measurement, age-related hearing impairment

NAV3 ZNF469 ITGB3BP

2.71e-0552333EFO_0005782, EFO_0009367
Diseaseosteoarthritis, spine, body mass index

PER3 CLIP1

3.38e-058332EFO_0004340, EFO_1000787
Diseaseinvasive ductal carcinoma (is_implicated_in)

RUNX3 UBR5

6.63e-0511332DOID:3008 (is_implicated_in)
Diseasereticulocyte count

SERTAD2 ZNF469 EBF1 RUNX3 MAST2 ATXN1L CLIP1

1.31e-041045337EFO_0007986
Diseaserisk-taking behaviour

ZFHX3 CDSN EBF1 NFAT5 TSHZ2 MTSS2

1.80e-04764336EFO_0008579
Diseaseglycoprotein measurement

ZFHX3 RUNX3 MTSS2

3.19e-04119333EFO_0004555
DiseaseAlzheimer disease, polygenic risk score

SERTAD2 MAST2 NFAT5 CLIP1 MTSS2

4.55e-04586335EFO_0030082, MONDO_0004975
DiseaseProstatic Neoplasms

ZFHX3 CHD6 TNFRSF21 IL6ST PYHIN1

5.71e-04616335C0033578
DiseaseMalignant neoplasm of prostate

ZFHX3 CHD6 TNFRSF21 IL6ST PYHIN1

5.71e-04616335C0376358
Diseasecortical surface area measurement

NAV3 ZFHX3 ZNF469 EBF1 MAST2 DCLK1 KIF1B

6.06e-041345337EFO_0010736
Diseasehypospadias

ZFHX3 EBF1

8.76e-0439332EFO_0004209
Diseasereticulocyte measurement

SERTAD2 ZNF469 EBF1 RUNX3 ATXN1L CLIP1

9.87e-041053336EFO_0010700
Diseaseheart failure

ZFHX3 NFAT5 ZNF592

1.15e-03185333EFO_0003144
DiseaseNeuroblastoma

CHD6 KIF1B

1.27e-0347332C0027819
Diseaselung adenocarcinoma (is_implicated_in)

ZFHX3 UBR5

1.38e-0349332DOID:3910 (is_implicated_in)
DiseaseCrohn's disease

CHD6 PER3 RUNX3 TSHZ2

1.43e-03441334EFO_0000384
Diseasepsoriasis

CDSN EBF1 RUNX3

3.48e-03273333EFO_0000676

Protein segments in the cluster

PeptideGeneStartEntry
KSSSSGHPCMSVSSL

CDSN

451

Q15517
RSTSDPTLCTSSMAG

FAM189A1

396

O60320
SSMAGDASSHRPSCS

FAM189A1

406

O60320
SKGAHTMCASSLSSP

LINS1

606

Q8NG48
TMCASSLSSPRASQS

LINS1

611

Q8NG48
PPTTSAAAAMSCTGS

MAGEB4

66

O15481
MGSLTSSPSSCSLSS

KIF1B

436

O60333
MGRTTSCSTNHTPSS

ATXN1L

26

P0C7T5
MTSSYSSSSCPLGCT

KRT38

1

O76015
GSSTSLASTKVCSSM

DCLK1

351

O15075
LGATASSAISPSMSS

PER3

871

P56645
SSSSSRKSSMCSAPS

MTSS2

266

Q765P7
RKSSMCSAPSSSSSA

MTSS2

271

Q765P7
ASPSGSCTMTVAQSS

NAV3

591

Q8IVL0
APSSSSMGGACSSFT

NFAT5

71

O94916
SMGGACSSFTTSSSP

NFAT5

76

O94916
TGTCQMSLFASPTSS

ITGB3BP

36

Q13352
SSCMSSSRPSISSSD

IL6ST

731

P40189
PMATTCTSTAPASLS

CHD6

2541

Q8TD26
PSCSAGASTSTAMGR

PYHIN1

161

Q6K0P9
SPTMASSTSLPSNCS

EBF1

521

Q9UH73
SSCSPPSSTSGKLSM

MAST2

1641

Q6P0Q8
TSPLCTSTASMVSSS

CLIP1

146

P30622
SPTRMLASCTSSAAS

RUNX3

356

Q13761
MGTSPSSSTALASCS

TNFRSF21

1

O75509
SSCSMACSLPSGADS

TCP11X1

266

B4DZS4
SSTSTPTSSCSMTAA

TMEM121B

121

Q9BXQ6
MPCTSASFSGGVSSS

TRO

816

Q12816
CTSSSGTASKMAPVS

SERTAD2

261

Q14140
PCGHRDSVSSSSSMS

PLCH2

1136

O75038
SMTKASDSSSPSCSS

ZNF592

451

Q92610
PSCSSPSSSTISMFH

TSHZ2

716

Q9NRE2
AGSTCSSLSPMSSSP

ZNF469

601

Q96JG9
TSSGSCSSMSDPGLN

WDR59

786

Q6PJI9
LGSCIESSSLGMSSS

TOPAZ1

1506

Q8N9V7
SSASACSPGGMLSSA

ZNF503

231

Q96F45
TCSDASSIASSASMP

UBR5

616

O95071
VTSSSCSTSGVQPSM

ZFHX3

3641

Q15911
TLTCTAVSSSDSPMS

LRIG2

516

O94898